Maruishi Pharmaceutical Report issue

For profit Phase 2 Phase 4
Founded: Osaka Japan (1888)

Organization Overview

First Clinical Trial
2005
NCT00318955
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Maruishi Pharmaceutical

Active Ingredients

Drugs in Phase 4 Trials (2)

dexmedetomidine (precedex) (5 trials)

propofol (diprivan) (1 trial)

Drugs in Phase 2 Trials (1)

difelikefalin (Korsuva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pruritus (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 3